Literature DB >> 2983593

Immunoglobulin G antibodies to lymphadenopathy-associated virus in differently treated French and Belgian hemophiliacs.

C Rouzioux, F Brun-Vezinet, A M Couroucé, C Gazengel, D Vergoz, J Desmyter, J Vermylen, C Vermylen, D Klatzmann, D Geroldi.   

Abstract

Immunoglobulin G antibodies to lymphadenopathy-associated virus have been detected in two groups of French hemophiliacs and in one group of Belgian hemophiliacs, whose mode of treatment differed. Seropositivity was more frequent (58.9%) in patients heavily transfused with blood products of French and foreign origin than in less frequently transfused persons (10.3%). The Belgian group, treated only with local products, showed the lowest frequency of seropositivity (3.4%). In healthy French controls, 1 of 330 had antibody to the virus. The results indicate transmission of lymphadenopathy-associated virus via blood-derived products.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983593     DOI: 10.7326/0003-4819-102-4-476

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

Review 1.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

2.  LAV/HTLV-III antibody status and immunological abnormalities in haemophiliac patients.

Authors:  J J Huart; M Maniez; A Parquet-Gernez; M Goudemand
Journal:  Blut       Date:  1987-02

3.  Physical condition, longevity, and social performance of Dutch haemophiliacs, 1972-85.

Authors:  C Smit; F R Rosendaal; I Varekamp; A Bröcker-Vriends; H Van Dijck; T P Suurmeijer; E Briët
Journal:  BMJ       Date:  1989-01-28

4.  [Viral safety of biologicals].

Authors:  F Barin
Journal:  Ann Pharm Fr       Date:  2008-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.